# ESy-Labs-GmbH

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/esy-labs-gmbh

- Industry: Chemicals
- Headquarters: Regensburg, Germany
- Website: www.esy-labs.de
- Total disclosed funding: $0.6M
- Latest round: Seed (Nov 17, 2022)
- Investors on record: 1

## About

Based in Regensburg, Germany, and founded in 2018 by Tobias Gartner, and Siegfried R. Waldvogel, ESy-Labs-GmbH, a spin-off from the Johannes-Gutenberg-University Mainz and the Fraunhofer Society, operates as a chemical manufacturing company that produces organic and inorganic raw materials using electrosynthesis technology. In November 2022, ESy-Labs-GmbH raised EUR 600,000 in seed funding from investor High-Tech Gründerfonds. The firm’s partners include Chemie Cluster Bayern, Wacker, Geltz, Fraunhofer IGB, etc. 

The company employs electrosynthesis and catalysis to produce chemical compounds such as active pharmaceutical ingredients and their precursors, fine chemicals line ESy-Organics, and metals as well as metal compounds (ESy-Inorganics). The firm provides substitute chemicals for toxic and expensive oxidizing and reducing agents, and offers consulting, custom electrosynthesis, and process development, to provide demand-based chemical manufacturing services.

The company intends to use the November 2022 funding to expand the technical equipment and hire additional employees to further advance the ESy screening technology.

## Funding rounds

- Seed, Nov 17, 2022, $0.6M — High-Tech Gruenderfonds

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed